ELEKTA AND SWEDFUND INVEST IN CANCER CARE IN DEVELOPING COUNTRIES

The medical technology company Elekta has formed an investment company, Global Medical Investments "GMI", with Swedfund International AB for financing and establishment of cancer care projects in developing countries.

Global Medical Investments, GMI, will invest, develop and support the establishment of cancer management programs in developing countries across the world in cooperation with local healthcare providers and partners. “We are very pleased that we, in cooperation with Swedfund, have been able to establish this investment vehicle for the development of cancer care programs in the most needing countries in the world. Our expertise in cancer and cancer management, combined with Swedfund’s long experience of successful development investments in third world countries, provide a unique opportunity to support the development of advanced health care in many developing countries”, says Dr Laurent Leksell, founder and Executive Director of Elekta AB. Through GMI, Swedfund and Elekta will be able to provide technology and competence for first class cancer management. Elekta and Swedfund will each invest up to USD 10 M in GMI. Through this initiative Elekta will also strengthen its presence in countries where the company has limited business activities. GMI is currently in the final stage of development of the first sophisticated radiotherapy center in Accra, Ghana. This is developed in close collaboration with Scandinavian Care Projects AB, which is leading this project, and with local partners. The cancer center is expected to initiate treatment in the first half of 2010, and will give the people in Ghana access to effective and cost efficient cancer treatment with Elekta’s latest technology. “We believe that this investment, with Swedish expertise in health care and medical technology, will contribute to increased availability of advanced medical care. Swedfund participated in the financing of the first GammaKnife in Africa, which is located in Egypt, and we are very pleased by this extended cooperation which we believe will lead to many new cancer centers in developing countries”, says Björn Blomberg, Managing Director of Swedfund. ****** For further information, please contact: Stina Thorman, Investor Relations, Elekta AB Tel: +46 8 587 257 34, +46 70 778 60 10, e-mail: stina.thorman@elekta.com Maria Lannér, Director Communications, Swedfund Tel: +46 8 725 94 17, +46 708 186808, e-mail: maria.lanner@swedfund.se